← Leaderboards
Joshua Andrew Kochanowsky
University Of Arizona
$327,436
Attributed
$327,436
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $159.6K · FY2019–25$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$327,436 · 3
By mechanism
K22$159,600 · 1
F31$91,052 · 1
F32$76,784 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Melissa Marie Herbst-Kralovetz$1,820,109
- Anita Koshy$5,886,857
- Fernando D Martinez$68,375,515
- Jefferey L Burgess$20,566,191
- Cynthia A Thomson$8,364,016
Others in their field
Other Emerging Leaders on “Immune”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmuneClinically RelevantPlayImmune ResponsePathway InteractionsFutureGenesInfectionMediatingCellsUptakeTranscriptome SequencingParasitesProteinsWestern BlottingPropertyNuclear TranslocationAffectPhysiologicalLeadCell CommunicationAllelesContractsAcute Infection
Grant awards (4)
Characterization of interferon epsilon mediated protection against Trichomonas vaginalis and its suppression by parasite extracellular vesicles$159,600
K22 · FY2025 · AI · contact PI
Elucidating the role of IFN epsilon mediated type I IFN responses against Trichomonas vaginalis$76,784
F32 · FY2024 · AI · contact PI
Role of ROP16 in Toxoplasma gondii Cyst Development$46,036
F31 · FY2021 · AI · contact PI
Role of ROP16 in Toxoplasma gondii Cyst Development$45,016
F31 · FY2019 · AI · contact PI